Population (Antibody) Testing for COVID-19—Technical Challenges, Application and Relevance, an English Perspective
Open Access
Abstract
In the UK, population virus or antibody testing using virus swabs, serum samples, blood spots or oral fluids has been performed to a limited extent for several diseases including measles, mumps, rubella and hepatitis and HIV. The collection of population-based infection and immunity data is key to the monitoring of disease prevalence and assessing the effectiveness of interventions such as behavioural modifications and vaccination. In particular, the biological properties of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its interaction with the human host have presented several challenges towards the development of population-based immunity testing. Measuring SARS-CoV-2 immunity requires the development of antibody assays of acceptable sensitivity and specificity which are capable of accurately detecting seroprevalence and differentiating protection from non-protective responses. Now that anti-COVID-19 vaccines are becoming available there is a pressing need to measure vaccine efficacy and the development of herd immunity. The unprecedented impact of the SARS-CoV-2 pandemic in the UK in terms of morbidity, mortality, and economic and social disruption has mobilized a national scientific effort to learn more about this virus. In this article, the challenges of testing for SARS-CoV-2 infection, particularly in relation to population-based immunity testing, will be considered and examples given of relevant national level studies.Keywords
This publication has 88 references indexed in Scilit:
- Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology, 2018
- Hosts and Sources of Endemic Human Coronaviruses2018
- Lateral flow assays: Principles, designs and labelsTrAC Trends in Analytical Chemistry, 2016
- The Coronavirus Nucleocapsid Is a Multifunctional ProteinViruses, 2014
- Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st centuryEpidemiology and Infection, 2006
- Sero-epidemiology of Bordetella pertussis in England and WalesVaccine, 2004
- The Prevalence of Hepatitis C in England and WalesJournal of Infection, 2002
- Immunity to diphtheria and tetanus in England and WalesVaccine, 2000
- Ten years of serological surveillance in England and Wales: methods, results, implications and actionInternational Journal of Epidemiology, 2000
- Virology: CoronavirusesNature, 1968